Pyxyo
Develops patented digital health, connected-device and cognitive-modulation technologies for healthcare and other specialized markets
Highlights
- New on EvolcAdded 2026-11-03
About Pyxyo
PYXYO develops a portfolio of technologies based on needs identified in practical settings. Its work spans healthcare software, miniaturized connected devices and cognitive-modulation hardware, with intellectual-property protection and French design and manufacturing as stated principles. Its available product SurgiUp supports care-team coordination and patient pathways.
PYXYO is based in Lyon, France, and was founded in 2005. It is led by practicing surgeon Dr Damien Van der Stegen.
Product: Develops healthcare coordination applications and patented connected-device and cognitive-modulation technologies.
Jobs at Pyxyo
More health & medtech companies
qare.fr
Online medical teleconsultations with registered French doctors for patients in France, available 7 days a weekNew on EvolcRemote-friendlyQuantificare
2D and 3D imaging systems and clinical imaging services for clinical-trial sponsors and aesthetics practitionersNew on EvolcQuantum Surgical
Robotic-assisted tumour ablation system for interventional radiologists treating early-stage cancers in hospitalsNew on EvolcQuinten Health
AI and real-world evidence analytics for pharmaceutical, biotech, medtech, hospital, and regulatory teamsYoung companyNew on EvolcQuiz Coach
Continuing education and digital tools for community pharmacy teams and pharmacistsNew on EvolcQynapse
AI-based neuroimaging software that quantifies MRI brain scans to support CNS disease diagnosis for clinicians and pharmaNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Hosting
- NetlifyHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-nf-request-id
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.